1. purpledeedee247
2. prewittv
3. hemzawi476
4. howiemas
5. d4ortie
1.prewittv 01/25/2018
Announces 'positive' 24-week interim results from the open-label Phase 2 proof of concept clinical trial, …
2.howiemas 01/26/2018
great rebound from yesterday
3.hemzawi476 01/26/2018
thank you for the heads up
4.purpledeedee247 02/26/2018
Announces further positive findings from PhaseOut DMD
5.purpledeedee247 03/10/2018
Summit Expands Enrolment in Phase 2 Clinical Trial to Include Planned Additional Group
6.purpledeedee247 01/26/2018
Good news for $SMMT? - Ezutromid Significantly Reduced Muscle Damage in DMD Patients in 24-Week Interim Data From Summit's PhaseOut DMD Clinical Trial
7.howiemas 03/27/2018
Summit Therapeutics Announces a Proposed Placing to Raise up to £15 Million
8.hemzawi476 01/25/2018
H.C. Wainwright & Co. reiterates Buy rating, $16 PT
9.hemzawi476 07/02/2018
Canaccord Genuity sets PT at $3
10.hemzawi476 01/26/2018
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW